Skip to main content
. Author manuscript; available in PMC: 2012 Jun 11.
Published in final edited form as: Biochem Pharmacol. 2007 Mar 12;73(12):1873–1886. doi: 10.1016/j.bcp.2007.03.002

Table 1. Cytotoxic activity of KP772 against various cell models at 72 h treatment.

Cell line Overexpressed protein Fold resistancea IC75 (μM)
IC50 (μM)
IC25 (μM)
Meanb ±S.D. Meanb ±S.D. Meanb ±S.D.
GLC-4 Parental - 0.92 0.03 1.31 0.03 2.16 0.04
GLC-4/adr ABCC1, LRP 0.61*** 0.64 0.03 0.80 0.02 0.96 0.02
HL60 Parental - 1.33 0.58 1.77 0.04 2.20 0.03
HL60/adr ABCC1 0.44*** 0.46 0.09 0.78 0.04 2.26 0.31
KB-3-1 Parental - 1.68 0.06 2.49 0.24 4.93 0.06
KBC-1 ABCB1 0.50* 0.82 0.03 1.43 0.17 3.51 0.44
MCF-7 Parental - 1.6 0.24 4.29 0.43 >10.0 -
MCF-7/bcrp ABCG2 0.54* 0.31 0.03 2.33* 0.21 >10.0 -
A459 ABCC1, ABCC2, ABCG2, LRP - 0.9 0.1 1.5 0.10 2.6 0.2
a

Differences in KP772 sensitivity calculated by dividing IC50 values of the MDR subline by those of the parental cell lines.

b

IC75, IC50, and IC25 were calculated from whole dose–response curves. Values given are means ± S.D. of 1 representative experiment out of three, performed in triplicates.

*

Significantly different from parental cell line ( p < 0.05).

***

Significantly different from parental cell line ( p < 0.001).